372 related articles for article (PubMed ID: 25420864)
1. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
[TBL] [Abstract][Full Text] [Related]
2. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.
Kontopidou F; Giamarellou H; Katerelos P; Maragos A; Kioumis I; Trikka-Graphakos E; Valakis C; Maltezou HC;
Clin Microbiol Infect; 2014 Feb; 20(2):O117-23. PubMed ID: 23992130
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes.
Mouloudi E; Massa E; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Piperidou M; Orphanou A; Passakiotou M; Imvrios G; Fouzas I; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3216-8. PubMed ID: 25420863
[TBL] [Abstract][Full Text] [Related]
4. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Bonomo RA; Kaye KS
Infect Control Hosp Epidemiol; 2015 Aug; 36(8):942-8. PubMed ID: 25990806
[TBL] [Abstract][Full Text] [Related]
5. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
[TBL] [Abstract][Full Text] [Related]
6. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
Ny P; Nieberg P; Wong-Beringer A
Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
[TBL] [Abstract][Full Text] [Related]
7. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
[TBL] [Abstract][Full Text] [Related]
8. [Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Huan J
Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):5-8. PubMed ID: 25876631
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
[TBL] [Abstract][Full Text] [Related]
10. Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
Zhang R; Dong N; Huang Y; Zhou H; Xie M; Chan EW; Hu Y; Cai J; Chen S
Emerg Microbes Infect; 2018 Jul; 7(1):127. PubMed ID: 29985412
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
van Duin D; Cober ED; Richter SS; Perez F; Cline M; Kaye KS; Kalayjian RC; Salata RA; Evans SR; Fowler VG; Bonomo RA
Clin Microbiol Infect; 2014 Dec; 20(12):O1117-20. PubMed ID: 24931918
[TBL] [Abstract][Full Text] [Related]
14. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
Büyüktuna SA; Hasbek M; Çelik C; Ünlüsavuran M; Avcı O; Baltacı S; Fırtına Topcu K; Elaldı N
Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
[TBL] [Abstract][Full Text] [Related]
15. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant
Li M; Wang X; Wang J; Tan R; Sun J; Li L; Huang J; Wu J; Gu Q; Zhao Y; Liu J; Qu H
Antimicrob Resist Infect Control; 2019; 8():8. PubMed ID: 30651974
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
Hu Y; Ping Y; Li L; Xu H; Yan X; Dai H
J Infect Dev Ctries; 2016 Mar; 10(3):208-13. PubMed ID: 27031451
[TBL] [Abstract][Full Text] [Related]
17. Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
Sheng ZK; Wang W; Guo Q; Xu X; Wang M; Yang Y; Wang M
J Microbiol Immunol Infect; 2016 Dec; 49(6):962-968. PubMed ID: 26692183
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Brizendine KD; Richter SS; Cober ED; van Duin D
Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
[TBL] [Abstract][Full Text] [Related]
20. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
